Histamine intolerance and SAMA
Histamine intolerance may (or may not) evolve into mast cell activation syndrome (MCAS). A wide range of symptoms presented by the individual who merits recognition by an arborescent practitioner who knows how to recognize symptoms and link them to histamine and mast cells with corresponding management.
Our approach to handling these two conditions is tree-based and multifactorial, based on the ADIMOGH method or the NSSR method, where applicable.
Our links in reference to histamine
Click below to download the documents you need.
Our book -
Histamine intolerance
Consultations
Consultations using the NSSR® and ADIMOGH®methods for chronic, long-standing health conditions and medical uncertainty involving excess histamine or SAMA.
Office consultations
Watch the explanatory video introducing the different types of sessions offered at the practice.
If you're not sure which appointment to choose or if you don't have a substantial medical history, please select the one-hour in-office appointment.
You can also call our office Monday through Friday, from 8 a.m. to 8 p.m. Our team will be happy to assist you and help you choose the appointment option that best suits your situation.
Video consultations
Watch the instructional video that explains the different types of remote sessions and the procedure for performing remote microscopy.
If you're not sure which appointment to choose or if you don't have a substantial medical history, please select the one-hour in-office appointment.
You can also call our office Monday through Friday, from 8 a.m. to 8 p.m. Our team will be happy to assist you and help you choose the appointment option that best suits your situation.
Our strengths
Reading of your preventive investigation analyses (LIMS/Barbier/Red labs/united labs...) and local laboratory analyses.
Read your own capillary sample for dark field analysis, coagulated blood, smear, whether remotely or at the office.
Use of different types of bioresonance to improve your physiological and micronutritional status.
